LB Pharmaceuticals Inc – Filings and Transcripts

NASDAQ: LBRX
Share price (6/9/26): $29.27
Market cap (6/9/26): $839 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus supplement

Prospectus supplement

Initial registration of new securities

Registration of securities for employees

Ownership Filter

Prensky Zachary

Kane William P Jr

Hemrajani Rekha

News Filter

Shareholder Vote Results

Reports First Quarter 2026 Financial Results and Provides Corporate Update

Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Change in Directors, Officers or Compensation

Appoints R&D Biotech Executive Robert Lenz, M.D., Ph.D. to Board of Directors

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness